A Mayo Clinic team developed an ionic liquid formulation that killed cancer cells and allowed for uniform distribution of a chemotherapy drug into liver tumors and other solid tumors. This discovery could solve challenges in drug delivery to tumors, particularly for patients with liver cancer awaiting a transplant.
A study by Mayo Clinic researchers found that certain biomarkers can help diagnose acute kidney inflammation in cancer patients treated with immune checkpoint inhibitors. These biomarkers, such as serum creatinine and C-reactive protein, may aid in distinguishing treatment-associated kidney injury from other causes.
Researchers at Mayo Clinic have developed an AI-powered mobile EKG device that can rapidly and accurately determine a patient's QTc, identifying those at risk of sudden cardiac death from congenital long QT syndrome or drug-induced QT prolongation. The device achieved high sensitivity and specificity in detecting clinically meaningful ...
Researchers at Mayo Clinic have developed the first hybrid gene therapy for treating long QT syndrome, a genetic heart rhythm condition. The therapy targets the KCNQ1 gene and has shown potential therapeutic efficacy in two in vitro model systems using beating heart cells reengineered from patient blood samples.
A new multi-institution study provides more accurate estimates of breast cancer risk for US women with inherited mutations in breast cancer predisposition genes. The findings may allow healthcare providers to better assess the risk of breast cancer and provide more appropriate risk management strategies.
A Mayo Clinic study found that age influences sex-related outcomes after a heart attack, with younger women being more likely to experience vascular complications and major bleeds. The study analyzed over 6.7 million hospitalization records and showed distinct differences in risk profiles for heart disease between men and women.
A retrospective study of 7,891 patients with COVID-19 treated at Mayo Clinic found lower mortality rates compared to national and international averages. The team-based approach, leveraging clinical trials and available therapies, and remote monitoring tools contributed to these favorable outcomes.
Researchers found that Black churches are trusted messengers of COVID-19 information, with high levels of community engagement and positive feedback. The FAITH! program helped establish emergency preparedness teams and culturally relevant messaging channels within participating churches.
A recent study found that only about 60% of patients with coronary artery disease, stroke, or peripheral artery disease receive the recommended statin therapy. Despite a decrease in drug cost, disparities persist in statin use among different age groups, genders, and racial backgrounds.
A recent study by Mayo Clinic researchers found significant changes in substance use among young adults during the COVID-19 pandemic. Nearly 70% of respondents increased alcohol consumption, while vaping decreased in 44% of people. The study suggests that loneliness, anxiety, and depression may fuel increases in substance use.
A new study found a correlation between RNA-binding protein clumping and protein aggregates in the hearts of patients with RBM20 dilated cardiomyopathy. This discovery suggests that RBM20 is an RNA-binding protein granule disease similar to Lou Gehrig's disease and Alzheimer's disease.
Researchers found that children who received antibiotics before age 2 were more likely to develop multiple illnesses or conditions later in childhood. These include allergic rhinitis, food allergies, attention deficit hyperactivity disorder, celiac disease, and atopic dermatitis.
Researchers found that neurofilament light protein levels in the blood can predict stroke severity and prognosis, as well as anticipate future recovery. Higher NFL levels forecast worse functional outcomes and shorter survival time after a stroke. This discovery establishes NFL as a promising prognostic biomarker for stroke.
A Mayo Clinic study found that 13.5% of cancer patients had inherited genetic mutations associated with their cancer development. The discovery could lead to targeted cancer therapies and improved survival rates for patients with these high-risk mutations.
A Mayo Clinic study analyzed Google web searches for keywords related to COVID-19, finding strong correlations with outbreaks in parts of the US up to 16 days prior. The study's findings suggest that analyzing internet surveillance data can help predict and respond to hot spots in a pandemic.
Researchers at Mayo Clinic have developed a potential test for Machado-Joseph disease, a rare neurodegenerative disorder with no cure. The new test can quantify mutant protein levels in human biofluids, which may help evaluate the effectiveness of therapies aimed at reducing protein accumulation.
A Mayo Clinic study found that patients with large polycystic kidneys can have their diseased kidneys removed laparoscopically at the same time as a kidney transplant, without compromising kidney function. The dual surgery approach has been shown to be a safe and viable option for these patients.
A Mayo Clinic study reveals that lung transplant patients who receive antifungal preventive medications have a significantly lower risk of death within the first year posttransplant. The study analyzed data from 667 patients and found that mortality risk was about twice as high in those not receiving treatment.
A new Mayo Clinic study found that clinical oncologists are less informed about the federal Right to Try (RTT) law, citing concerns over patient safety and regulatory burden. The study also revealed that most oncologists had limited familiarity with RTT despite having experience with FDA's Expanded Access Programs.
Researchers created an index that distinguishes between healthy and diseased gut microbiomes based on a biologically-interpretable mathematical formula. The Gut Microbiome Health Index predicts the likelihood of having a disease independent of clinical diagnosis, with high accuracy rates.
A new clinical trial, TAILOR-PCI, found that genetic testing can identify patients who may benefit from alternative antiplatelet therapy. The study showed a statistically significant 40% reduction in blood clotting events in patients with the CYP2C19 gene variation who received genotype-guided treatment.
A study by Mayo Clinic researchers found that online searches for 'chest pain' increased by at least 34% during the COVID-19 pandemic, while emergency visits for heart attacks dropped. This suggests that people may be misconstruing chest pain as an infectious symptom or avoiding medical care due to pandemic concerns.
A study published in Menopause: The Journal of the North American Menopause Society found that women with a history of high blood pressure disorders during pregnancy reported more bothersome menopausal symptoms. Women using hormone therapy also experienced more severe symptoms compared to those without a high blood pressure history.
A study by Mayo Clinic researchers found that emergency department visits declined by 42-64% during the four-month period, with largest declines seen in areas with high COVID-19 cases. Hospital admissions remained relatively stable until local increases in COVID-19 cases led to dramatic upticks.
A new study published in Clinical Infectious Diseases suggests that phage therapy could be a game-changer in treating complex bacterial infections in prosthetic joints. The treatment has shown promising results in patients with biofilm-related infections, which are notoriously difficult to eradicate with antibiotics.
Researchers at Mayo Clinic have found that investigational convalescent plasma is safe to use in a diverse group of 20,000 patients, with a significant decline in seven-day mortality rates compared to previous studies. The study also found lower serious adverse events and a more rapid availability of plasma for treatment.
A clinical trial found that olanzapine significantly improved patient quality of life by reducing nausea and vomiting scores. The study showed that patients who received olanzapine reported less vomiting, better appetite, and better well-being compared to those who received a placebo.
Researchers at Mayo Clinic have discovered a potential link between heart disease and worse COVID-19 outcomes. The study found that patients with obstructive hypertrophic cardiomyopathy had elevated levels of the ACE2 protein, which the SARS-CoV-2 virus uses to gain entry into cells.
A study published in JAMA Network Open found that more than half of Americans starting highly regulated opioids may be receiving inappropriate treatment. The research team used pharmacy and medical claims data to identify nearly 300,000 instances of prescriptions for medications reserved for people with opioid tolerance. However, less ...
The article proposes algorithms for evaluating patients with suspected or confirmed COVID-19 and signs of acute heart attack, guiding triage and treatment. Mayo Clinic cardiologists and radiologists emphasize the importance of immediate and appropriate treatment to minimize risks for both patients and medical staff.
A Mayo Clinic article highlights the risks of relying on COVID-19 testing, citing the high sensitivity of reverse transcriptase-polymerase chain reaction (RT-PCR) testing and its limitations in ruling out the disease. Health care officials are advised to consider patient characteristics and exposure when interpreting test results.
Researchers at Mayo Clinic discovered that fetal surgery to correct congenital spinal cord defects is more effective at healing neurological structure than surgery after birth. The procedure led to improved brain structure and anatomy in three patients with myelomeningocele.
The Mayo Clinic has provided guidance on how to use ECGs to monitor patients at risk of drug-induced sudden cardiac death due to COVID-19. The guidelines aim to minimize the chance of fatal arrhythmias, particularly for patients taking antimalarial drugs like hydroxychloroquine.
A study published in Mayo Clinic Proceedings found that homeless patients admitted with a heart attack often received less treatment, had longer hospital stays, and were more likely to be readmitted. These patients also faced unique challenges due to high rates of mental illness, substance abuse, and HIV infections.
Researchers have uncovered mechanisms of healing after a heart attack using human cardiopoietic cells, which restored cardiac muscle to its pre-attack state. The study found that these cells reversed two-thirds of the changes caused by a heart attack, with 85% of cellular functional categories responding favorably to treatment.
A new Mayo Clinic study found no link between surgery with general anesthesia and the indicator of Alzheimer's disease. Cortical thinning in cerebral areas was observed, but no significant evidence of amyloid protein deposits, a hallmark of Alzheimer's, was detected.
A Mayo Clinic-led study reveals that rapid fat degradation occurs in acute pancreatitis, triggered by PNLIP enzyme, and worsens disease outcomes. Obesity exacerbates pancreatitis risk, while unsaturated fats increase organ failure risk.
A new study by Mayo Clinic researchers found that catheter ablation reduced the risk of death or hospitalization due to worsening heart failure in patients with both conditions. The study analyzed data from over 289,000 patients and showed an 18% reduction in risk for those who received ablation.
Researchers discovered that a Mx protein, called MxB, helps cells fight viral infections by supporting mitochondrial function and integrity. The study provides new insights into the role of MxB in cellular defense against viral infections.
A Mayo Clinic study found that genetic variants on chromosomes 1 and 5 were linked to higher tau levels in older adults. Participants with these variants had about 10% higher tau levels than those without them. The research suggests that genes previously linked to Alzheimer's risk may not be associated with tau accumulation.
A new framework for managing chronic pain in older adults emphasizes the importance of combining pharmacologic strategies with nondrug therapies. The 'start low, go slow' approach suggests beginning with low-risk, noninvasive options that involve patients in their own care, while judiciously using higher-risk treatments as needed.
Researchers at Mayo Clinic have found that combining density of immune cells with analysis of tumor budding can improve accuracy in predicting patient survival for patients with stage III colon cancer. This method provides important data on patient survival and may lead to personalized treatment recommendations.
A study by Mayo Clinic researchers suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing. This approach would identify 98% of women with BRCA1 and BRCA2 mutations, while avoiding testing of 20% of all breast cancers.
A new study found that people with Type 2 diabetes in the US often receive treatment that is too aggressive or not aggressive enough, with those who are most likely to benefit from intensive therapy being underserved. The study suggests a fine line between effective treatment and increased risk of hypoglycemia.
Researchers at Mayo Clinic have created an artificial intelligence (AI) algorithm that can detect unseen characteristics of hypertrophic cardiomyopathy using standard EKGs. The AI's ability to diagnose the disease was found to be highly accurate, with an area under the curve of 0.96, outperforming traditional tests.
The study evaluated nationwide data from 2003 to 2016, assessing changes in the risk profiles and number of patients undergoing revascularization. It found an increase in elderly patients, racial minorities, and those with lower income, as well as a decrease in the use of coronary artery bypass grafting.
Researchers at Mayo Clinic have discovered a method to make tumor cells more responsive to immunotherapy. By promoting genetic mutations in tumor cells, they found that these cells become vulnerable to immune system attacks. The approach showed promise across different types of tumors and patient genomes.
Researchers propose evaluating vascular function in women starting in middle age to detect early signs of vascular aging and reduce heart disease risk. This approach could help establish a baseline of vascular health, measure effectiveness of lifestyle changes and clinical treatment for cardiovascular disease.
In a new study, Mayo Clinic researchers discovered that in-home bilevel positive airway pressure (BiPAP) therapy can significantly improve COPD patient outcomes, including reduced mortality rates and fewer hospital admissions. The treatment helps alleviate shortness of breath and reduces the risk of intubation.
A Mayo Clinic medical student has developed a curriculum to train fellow students to identify and provide resources to potential human trafficking victims. The study highlights the need for standardized training resources in medical schools to recognize the signs of trafficking and care for these patients.